ES556233A0 - Procedimiento para preparar un polipeptido - Google Patents

Procedimiento para preparar un polipeptido

Info

Publication number
ES556233A0
ES556233A0 ES556233A ES556233A ES556233A0 ES 556233 A0 ES556233 A0 ES 556233A0 ES 556233 A ES556233 A ES 556233A ES 556233 A ES556233 A ES 556233A ES 556233 A0 ES556233 A0 ES 556233A0
Authority
ES
Spain
Prior art keywords
sequence
dna
ligation
coli
cleavage site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556233A
Other languages
English (en)
Other versions
ES8706818A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8706818A1 publication Critical patent/ES8706818A1/es
Publication of ES556233A0 publication Critical patent/ES556233A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/71Expression systems using regulatory sequences derived from the trp-operon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Complex Calculations (AREA)
  • Advance Control (AREA)
ES556233A 1985-04-19 1986-06-19 Procedimiento para preparar un polipeptido Expired ES8706818A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853514113 DE3514113A1 (de) 1985-04-19 1985-04-19 Veraenderung der dna-sequenz zwischen shine-dalgarno-sequenz und startcodon des trp-operons zur steigerung der proteinexpression

Publications (2)

Publication Number Publication Date
ES8706818A1 ES8706818A1 (es) 1987-07-01
ES556233A0 true ES556233A0 (es) 1987-07-01

Family

ID=6268543

Family Applications (2)

Application Number Title Priority Date Filing Date
ES554097A Expired ES8704541A1 (es) 1985-04-19 1986-04-17 Procedimiento para la preparacion de un vector con el sistema de expresion en trp
ES556233A Expired ES8706818A1 (es) 1985-04-19 1986-06-19 Procedimiento para preparar un polipeptido

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES554097A Expired ES8704541A1 (es) 1985-04-19 1986-04-17 Procedimiento para la preparacion de un vector con el sistema de expresion en trp

Country Status (19)

Country Link
EP (1) EP0198415B1 (es)
JP (1) JPH0665317B2 (es)
KR (1) KR940004543B1 (es)
AT (1) ATE44046T1 (es)
AU (1) AU600229B2 (es)
CA (1) CA1321963C (es)
DE (2) DE3514113A1 (es)
DK (1) DK172695B1 (es)
ES (2) ES8704541A1 (es)
FI (1) FI84362C (es)
GR (1) GR861022B (es)
HU (1) HU196458B (es)
IE (1) IE58994B1 (es)
IL (1) IL78529A (es)
NO (1) NO175646C (es)
NZ (1) NZ215858A (es)
PH (1) PH26596A (es)
PT (1) PT82417B (es)
ZA (1) ZA862925B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966849A (en) * 1985-09-20 1990-10-30 President And Fellows Of Harvard College CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression
AU8379991A (en) * 1990-09-14 1992-03-26 Astra Aktiebolag A novel method of generating clones for the expression of unfused proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60188077A (ja) * 1984-03-09 1985-09-25 Teruhiko Beppu 仔牛プロキモシンcDΝAの全配列を有する新規な発現プラスミド
DE3430683A1 (de) * 1984-08-21 1986-03-06 Hoechst Ag, 6230 Frankfurt Synthetische regulationsregion

Also Published As

Publication number Publication date
EP0198415A2 (de) 1986-10-22
DE3663956D1 (en) 1989-07-20
ES8706818A1 (es) 1987-07-01
NZ215858A (en) 1989-01-06
JPH0665317B2 (ja) 1994-08-24
CA1321963C (en) 1993-09-07
ATE44046T1 (de) 1989-06-15
EP0198415B1 (de) 1989-06-14
AU5638786A (en) 1986-10-23
HU196458B (en) 1988-11-28
DE3514113A1 (de) 1986-10-23
IE58994B1 (en) 1993-12-15
PT82417B (pt) 1988-08-17
KR860008286A (ko) 1986-11-14
EP0198415A3 (en) 1986-12-30
GR861022B (en) 1986-08-18
ES8704541A1 (es) 1987-04-01
FI84362B (fi) 1991-08-15
IL78529A (en) 1991-07-18
DK172695B1 (da) 1999-05-31
IL78529A0 (en) 1986-08-31
DK179686A (da) 1986-10-20
FI861624A0 (fi) 1986-04-17
FI84362C (fi) 1991-11-25
DK179686D0 (da) 1986-04-18
ES554097A0 (es) 1987-04-01
JPS61242583A (ja) 1986-10-28
AU600229B2 (en) 1990-08-09
PT82417A (de) 1986-05-01
NO861551L (no) 1986-10-20
NO175646B (es) 1994-08-01
KR940004543B1 (ko) 1994-05-25
IE861031L (en) 1986-10-19
NO175646C (no) 1994-11-09
HUT41068A (en) 1987-03-30
FI861624A (fi) 1986-10-20
ZA862925B (en) 1986-12-30
PH26596A (en) 1992-08-19

Similar Documents

Publication Publication Date Title
IE872455L (en) Improved recombinant expression
AU568067B2 (en) Oligonucleotide therapeutic agent and methods of making same
DE68922917T2 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
DK567087A (da) Dna-sekvens, der koder for et protein med i alt vaesentligt samme biologiske aktivitet som humanprotein c, samt fremgangsmaade til fremstilling af dette protein
DE3851399T2 (de) Transientes Expressionssystem zur Herstellung von rekombinantem Protein.
ES2000278A6 (es) Procedimiento para preparar una proteina de fusion y para preparar una proteina eucariotica.
ES556233A0 (es) Procedimiento para preparar un polipeptido
KOPCHICK et al. Use of Avian Retro viral-Bovine Growth Hormone DNA Recombinants to Direct Expression of Biologically Active Growth Hormone by Cultured Fibroblasts
IE870220L (en) Human lymphotoxin polypeptide derivatives
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
EP0112012A3 (en) Recombinant DNA molecules
SE8100241L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos proinsulinet av primater, dna och plasmider, vilka kodierar for denna sekvens mikroorganismer, som innehaller dessa genetiska informationer, ...
GB2223495A (en) Gene encoding human basic fibroblast growth factor
GB2223496A (en) Gene encoding human acidic fibroblast growth factor
GB2210618A (en) Synthetic gene
GB2223497A (en) Gene encoding human beta-endothelial cell growth factor

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070514